ENTITY

Neurocrine Biosciences (NBIX US)

29
Analysis
Health CareUnited States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Company Event09 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event02 Dec 2025 22:30 • Latest
Company Event18 Nov 2025 20:00
Company Event29 Oct 2025 04:30
Company Event13 Aug 2025 20:00
x